Stock Events

Stock Events

KalVista Pharmaceuticals (KALV) Q1 2026 Earnings

25MarConfirmed

Q3 2025

Q3 2025

Q4 2025

Q1 2026

-1.12

-0.91

-0.7

-0.49

Details

Expected EPS

-0.672222

Actual EPS

-0.49

Surprise EPS

0.18

Surprise Percent

+27.11%

Description

KalVista Pharmaceuticals (KALV) has reported earnings of -0.49 per share for Q1 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.